Septicemia

20 registered clinical trials studyying Septicemia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Acid Base Disorders in ICU in Minia University Hospital NCT07148440	Minia University	—
Active Not Recruiting	A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning NCT05893420	AgileMD, Inc.	N/A
Completed	Monitoring Mitophagy In Myeloid Cells Upon Intensive Care NCT05040503	Centre Hospitalier Universitaire Dijon	N/A
Completed	Impact of Aminoglycosides in Hypotensive Septic Oncology Patients NCT05045963	M.D. Anderson Cancer Center	—
Completed	Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock NCT05358912	Bozyaka Training and Research Hospital	Phase 4
Active Not Recruiting	Correlating MicroRNA Changes With Sepsis Outcomes NCT03929159	M.D. Anderson Cancer Center	—
Unknown	Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique NCT03583762	Chiang Mai University	N/A
Completed	Evaluation of an Internal Hospital Practice: The Effect of Altered Test Tubes Sampling Order on Blood Culture NCT03088865	Hadassah Medical Organization	N/A
Unknown	Efficacy and Safety of Colistin Based Antibiotic Therapy NCT04764058	Ain Shams University	Phase 1 / Phase 2
Completed	Clinical Impact of the FilmArray Blood Culture Identification Panel Performed on Positive Blood Cultures From NCT03943719	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	—
Completed	Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious NCT02988414	Karius, Inc.	—
Completed	Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device NCT02102087	Magnolia Medical Technologies, Inc.	N/A
Unknown	Effectiveness of Different Interventions for Implementing Surviving Sepsis Campaign (SSC) Guidelines on Compli NCT02069028	King Abdullah International Medical Research Center	—
Terminated	Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral NCT02093494	Magnolia Medical Technologies, Inc.	N/A
Completed	National Study on Listeriosis and Listeria NCT01520597	Assistance Publique - Hôpitaux de Paris	—
Completed	Understanding the Immune Response to Meningitis Vaccines NCT00901940	University of Oxford	Phase 3
Unknown	Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests NCT00258869	National Center for Genome Resources	—
Completed	A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis NCT00046072	Eisai Inc.	Phase 2
No Longer Available	Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bac NCT04636554	Adaptive Phage Therapeutics, Inc.	—
Completed	Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1) NCT00146432	Charite University, Berlin, Germany	Phase 2 / Phase 3